Hunter Perkins Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Hunter Perkins Capital Management, LLC
- $451 Million
- Q3 2025
A detailed history of Hunter Perkins Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 11,616 shares of REGN stock, worth $8.06 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
11,616
Previous 8,473
37.09%
Holding current value
$8.06 Million
Previous $4.45 Million
46.83%
% of portfolio
1.45%
Previous 1.05%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,469Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...